Screener
Recursion Pharmaceuticals, Inc. RXRX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $12,672 | $18,118 |
| Accrued expenses and other liabilities | 56,936 | 70,230 |
| Unearned revenue | 27,586 | 37,605 |
| Operating lease liabilities | 13,249 | 12,663 |
| Notes payable and financing lease liabilities | 9,443 | 9,091 |
| Total current liabilities | 119,886 | 147,707 |
| Unearned revenue, non-current | 112,818 | 114,012 |
| Operating lease liabilities, non-current | 39,193 | 46,647 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported operating lease liabilities (current) of $13.25M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s operating lease liabilities (current) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s operating lease liabilities (current) increased by 12.9% year-over-year, from $11.73M to $13.25M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Recursion Pharmaceuticals, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude